AlmiRNA(s)DovepressmiR1273p, miR-148b, miR376a, miR376c, miR

AlmiRNA(s)DovepressmiR1273p, miR-148b, miR376a, miR376c, miR4093p, miR652, miRsubmit your manuscript | www.dovepress.commiR133a, miR-148bmiRmiR-148b, miR376c, miR4093p, miRmiR-155, miRmiRmiRNotes: This really is a representative sample of 20 current studies identified on a PubMed query (breast cancer blood miRNA miR) that describe individual miRNAs or miRNA signatures obtaining prospective application for early illness detection. Research with fewer than 20 BC cases have been excluded. Although these signatures mainly reflect larger amounts of circulating miRNAs, some miRNAs are detected at Dacomitinib Reduced levels in blood samples of BC patients. Blood collection was performed ahead of surgery unless otherwise indicated. miRNAs shown in bold indicate a recurrent presence in at the least three independent studies. Abbreviations: BC, breast cancer; DCiS, ductal carcinoma in situ; eR, estrogen receptor; LN, lymph node status; miRNA, microRNA; qRTPCR, quantitative realtime polymerase chain reaction.Breast Cancer: Targets and Therapy 2015:DovepressDovepressmicroRNAs in breast cancerTable two miRNArelated threat loci connected with BCGene locus MIR27A SNP rs895919 *C Comments Population purchase CX-5461 Asians Caucasians Jewish BRCA2 carriers Caucasian Asians Caucasians Chinese (young) Chinese Asians Caucasians African Americans African Americans european Americans Chinese Chinese African Americans european Americans African Americans european Americans italian Caucasians Chinese Asians Caucasians Asians Asians Caucasians Chinese Asians Caucasians Chinese Asians Caucasians African Americans African Americans Korean italian and German Asians Caucasians Brazilian Caucasian Chinese and Korean Chinese Chinese African Americans european Americans Asians Caucasians African Americans european Americans African a0023781 Americans African Americans european Americans African Americans european Americans Asians Caucasians Clinical observation No danger association Protective dar.12324 enhanced danger Decreased danger No threat association Decreased danger Decreased threat Decreased danger No danger association No risk association enhanced survival No threat association Decreased all round risk increased danger enhanced danger No danger association elevated general threat Decreased threat of eR+ BC No danger association earlier age of onset No danger association No danger association No threat association No threat association Decreased risk (C allele) No danger association No threat association No risk association No threat association No danger association No danger association No threat association No risk association Reduced risk Reduced threat Survival of HeR2+ situations No threat association Decreased danger No threat association Decreased threat Decreased risk Decreased risk increased risk improved threat No threat association No danger association No risk association No risk association Decreased danger of eR- BC No risk association increased survival elevated danger of eR- BC No threat association No risk association enhanced all round risk No threat association No danger association Reference 141 142 143 144 35 34 31 145 33 38 38 33 33 146 147 83 38 144 31 36 38 36 31 145 145 148 37 141 149 147 32 36 83 33 31 33 145 33 33rs895819 A/GpremiRNA premiRNA premiRNA premiRNAMIR34B cluster MIR100 MIR101-2 MIR106B MIR122A MIR146Ars4938723 T/C rs1834306 G/A rs1053872 C/G rs462480 A/C rs1527423 A/G rs17669 A/G rs2910164 G/C Primary transcript Key transcriptMIRrs2292832 T/GMIR185 MIR196A-rs2008591 C/T rs887205 A/G rs11614913 T/CMIR204 MIR206 MIR219 MIR331 MIRrs7861254 G rs6920648 A/G rs107822 G/A rs.AlmiRNA(s)DovepressmiR1273p, miR-148b, miR376a, miR376c, miR4093p, miR652, miRsubmit your manuscript | www.dovepress.commiR133a, miR-148bmiRmiR-148b, miR376c, miR4093p, miRmiR-155, miRmiRmiRNotes: This really is a representative sample of 20 recent studies identified on a PubMed query (breast cancer blood miRNA miR) that describe person miRNAs or miRNA signatures having potential application for early illness detection. Studies with fewer than 20 BC cases had been excluded. Although these signatures primarily reflect greater amounts of circulating miRNAs, some miRNAs are detected at decrease levels in blood samples of BC patients. Blood collection was performed ahead of surgery unless otherwise indicated. miRNAs shown in bold indicate a recurrent presence in at the least three independent studies. Abbreviations: BC, breast cancer; DCiS, ductal carcinoma in situ; eR, estrogen receptor; LN, lymph node status; miRNA, microRNA; qRTPCR, quantitative realtime polymerase chain reaction.Breast Cancer: Targets and Therapy 2015:DovepressDovepressmicroRNAs in breast cancerTable two miRNArelated risk loci related to BCGene locus MIR27A SNP rs895919 *C Comments Population Asians Caucasians Jewish BRCA2 carriers Caucasian Asians Caucasians Chinese (young) Chinese Asians Caucasians African Americans African Americans european Americans Chinese Chinese African Americans european Americans African Americans european Americans italian Caucasians Chinese Asians Caucasians Asians Asians Caucasians Chinese Asians Caucasians Chinese Asians Caucasians African Americans African Americans Korean italian and German Asians Caucasians Brazilian Caucasian Chinese and Korean Chinese Chinese African Americans european Americans Asians Caucasians African Americans european Americans African a0023781 Americans African Americans european Americans African Americans european Americans Asians Caucasians Clinical observation No threat association Protective dar.12324 improved risk Decreased danger No risk association Decreased risk Decreased danger Decreased threat No threat association No danger association enhanced survival No danger association Decreased all round risk enhanced risk improved danger No threat association elevated all round danger Decreased threat of eR+ BC No threat association earlier age of onset No threat association No risk association No danger association No danger association Decreased threat (C allele) No threat association No threat association No danger association No danger association No threat association No threat association No danger association No threat association Reduced risk Reduced danger Survival of HeR2+ circumstances No danger association Decreased danger No danger association Decreased risk Decreased danger Decreased danger enhanced danger elevated threat No danger association No danger association No danger association No threat association Decreased danger of eR- BC No risk association enhanced survival improved danger of eR- BC No threat association No danger association elevated all round threat No danger association No danger association Reference 141 142 143 144 35 34 31 145 33 38 38 33 33 146 147 83 38 144 31 36 38 36 31 145 145 148 37 141 149 147 32 36 83 33 31 33 145 33 33rs895819 A/GpremiRNA premiRNA premiRNA premiRNAMIR34B cluster MIR100 MIR101-2 MIR106B MIR122A MIR146Ars4938723 T/C rs1834306 G/A rs1053872 C/G rs462480 A/C rs1527423 A/G rs17669 A/G rs2910164 G/C Main transcript Main transcriptMIRrs2292832 T/GMIR185 MIR196A-rs2008591 C/T rs887205 A/G rs11614913 T/CMIR204 MIR206 MIR219 MIR331 MIRrs7861254 G rs6920648 A/G rs107822 G/A rs.